San Francisco, May 29, 2025 – Yoneda Labs, a leader in computational tools for reaction optimization, has successfully collaborated with Symeres, a leading transatlantic, small molecule contract research and manufacturing organization. The aim was to optimize transition metal catalyzed cross-coupling reactions to improve reaction yield and efficiency utilizing Yoneda Labs’ cutting-edge software.
The collaboration focused on streamlining the reaction optimization process with improved reaction yields of ~30% to >90%. By leveraging advanced predictive modeling and data-driven insights, Symeres identified four diverse reaction conditions with in situ yields of over 90%, significantly accelerating the development process compared to traditional one factor at a time (OFAT) or Design of Experiments (DoE) approaches.
“By integrating computational intelligence into experimental workflows, we’re helping chemists optimize their processes in days instead of months, significantly increasing their capacity to take on new projects.” Said Dr Olga Sokolova, SME in Chemocatalysis and DoE at Symeres. She added “The technology allows us to rapidly pinpoint high-yielding conditions making it an extremely helpful tool for process research by avoiding lengthy iterative screenings”
Michał Mgeładze-Arciuch, CEO at Yoneda Labs added “This case study demonstrates how Yoneda’s software empowers chemists to find the best reaction conditions faster and with greater confidence. I’m delighted that our software allows our customers to efficiently navigate complex reaction landscapes, saving valuable time and resources in the process of drug discovery and development.”
“This case study reflects Symeres’ ongoing commitment to embracing innovative technologies to accelerate and enhance chemical development.” said Andre de Vries, Director of Innovation at Symeres.
“We’re not just optimizing reactions; we’re redefining what efficiency and innovation look like for our clients. We’re excited to continue building on this success in the future as this collaboration with Yoneda Labs has shown how AI can help drive smarter, faster discoveries across the industry.”
For more information about Yoneda Labs and its technology, visit www.yonedalabs.com.
Media Contact:
Yoneda Labs
Michael Mgeładze-Arciuch
CEO
michal@yonedalabs.com
+1 510 977 3726
Symeres
Aranda Rahbarkouhi
RA Marketing | aranda@ramarketingpr.com
Latest news
Symeres earns first SBTi approval as part of long-term sustainability journey
Symeres appoints Gabriella Gentile as Chief Operating Officer to drive transatlantic growth
Symeres announces acquisition of DGr Pharma
New production lines D1 and D2 at our Prague site
New NMR technology – meet “Maggie”
Symeres announces leadership evolution
Official opening of new Oncolines home, the Marie Curie Building at the Pivot Park in Oss, the Netherlands
New equipment at Exemplify
New 100 L vessels in Groningen
Organix: New facility
Innovative macrocycles as powerful Mcl-1 inhibitors
Oncolines unveils new state-of-the-art laboratories
Peter Molenveld assumes role as secretary of KNCV (Royal Netherlands Chemical Society)
Chiral chemistry: in the DNA of Symeres
π-facial selectivity in the Diels–Alder reaction of glucosamine-based chiral furans and maleimides
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US
Expansion of solid-state center of excellence
Introducing Petr Cermak: “Returning to Prague feels like coming back for the future.”
Symeres acquires Massachusetts-based Organix Inc., adding lipids expertise and creating a strategic foothold in the US market
Expanding the toolbox: Resolving racemates
Symeres joins forces with Keensight Capital
Speak with our experts
Let’s discuss how Symeres can support the discovery and development of your next breakthrough